Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis
暂无分享，去创建一个
S. Cole | K. Altmann | A. Steyn | A. Benjak | J. Piton | Anthony Vocat | Andréanne Lupien | Kevin Pethe | Dirk A. Lamprecht | M. Kienle | C. Foo | Raphael Sommer